Overview
Douglas Turner is a Surgical Oncologist practicing medicine in Columbia, Maryland.
Dr. Turner is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Neonatal Severe Hyperparathyroidism, Thyroidectomy, and Parathyroidectomy.
Dr. Turner is board certified in American Board Of Surgery - Surgery (General Surgery), 2002 and American Board Of Surgery - Surgery (General Surgery), 2006. He is actively involved in clinical research, co-authoring 54 peer reviewed articles. Dr. Turner is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
Locations
5900 Waterloo Road, Suite 250, Columbia, MD 21045
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Maryland Orthopaedics Columbia
Vincent Ng is an Orthopedics specialist and a Surgical Oncologist practicing medicine in Columbia, Maryland. Dr. Ng is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Epithelioid Sarcoma, Osteotomy, and Hip Replacement. Dr. Ng is board certified in American Board Of Orthopaedic Surgery - Orthopaedic Surgery, 2016. Dr. Ng is currently accepting new patients.
Johns Hopkins Howard County Medical Center
Dr. Susan Bahl, MD, FACS, is a distinguished Breast Surgeon who recently joined Johns Hopkins, practicing at both Howard County Medical Center and Johns Hopkins Bayview Medical Center. A strong advocate for women's health, Dr. Bahl brings over a decade of experience in providing state-of-the-art, evidence-based breast care within multidisciplinary settings. She has a passion for delivering personalized treatment plans to patients, specializing in both benign and malignant breast diseases. Before joining Johns Hopkins, Dr. Bahl served as the Medical Director of the Frederick Health Breast Center, where she founded a NAPBC-accredited multidisciplinary breast cancer clinic. In this role, she helped streamline the treatment process for newly diagnosed breast cancer patients by coordinating care between breast surgeons, medical oncologists, and radiation oncologists. Dr. Bahl also co-directed a Breast Screening and Prevention Program designed for high-risk women, integrating genetic testing, risk-reduction surgeries, and chemo-prevention strategies. Her commitment to patient-centered care and leadership in breast health make her a valuable addition to the Johns Hopkins community. Dr. Bahl is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy. Dr. Bahl is board certified in American Board Of Surgery. Dr. Bahl is currently accepting new patients.
UMM Surgical Oncology Columbia
Benjamin Powers is a Surgical Oncologist practicing medicine in Columbia, Maryland. Dr. Powers is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, Ureteroscopy, and Bladder Reconstruction. Dr. Powers is board certified in American Board Of Surgery - Surgery (General Surgery), 2019 and American Board Of Surgery - Complex General Surgical Oncology, 2020. Dr. Powers is currently accepting new patients.
Johns Hopkins Outpatient Center
Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy. Dr. He is board certified in American Board Of Surgery. Dr. He is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Burkhart is board certified in American Board Of Surgery. Dr. Burkhart is currently accepting new patients.
Johns Hopkins Outpatient Center
Dr. Cameron has had a long and distinguished career in alimentary tract diseases and specifically in pancreatic cancer. He has won worldwide acclaim for mastering the Whipple procedure. At the beginning of his career, the mortality rate from the Whipple procedure was nearly 30 percent. He has worked to lower that to 1 percent to 2 percent at Johns Hopkins. He has operated on more patients with pancreatic cancer and done more Whipple resections than any other surgeon in the world. In addition to maintaining a busy practice that focuses mainly on pancreatic surgery, he has been a leader in the surgical profession, serving as president of the American College of Surgeons, Society for Surgery of the Alimentary Tract, Southern Surgical Association, Society of Clinical Surgery, Society of Surgical Chairmen, Halsted Society and American Surgical Association. He served as chief of surgery for The Johns Hopkins Hospital for nineteen years. Dr. Cameron obtained his undergraduate degree from Harvard University in 1958, and his medical degree from The Johns Hopkins University School of Medicine in 1962. All of his training in General and Thoracic Surgery was obtained at The Johns Hopkins Hospital. Dr. Cameron is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Cameron is board certified in American Board Of Thoracic Surgery and American Board Of Surgery. Dr. Cameron is currently accepting new patients.
Frequently Asked Questions about Dr. Douglas J. Turner
How do I make an appointment with Dr. Douglas J. Turner?
You can book an appointment with Dr. Douglas J. Turner by calling their office at 410-328-6187. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Douglas J. Turner a top-rated expert for Thyroid Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Douglas J. Turner is classified as an Distinguished expert for Thyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Douglas J. Turner specialize in?
While Dr. Douglas J. Turner is a Surgical Oncology, they have specific expertise in Thyroid Cancer, Follicular Thyroid Cancer, and Thyroidectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Surgical Oncology.
Does Dr. Douglas J. Turner participate in research or clinical trials?
Yes. Dr. Douglas J. Turner has published 54 articles and abstracts on conditions like Thyroid Cancer. You can view a list of Dr. Douglas J. Turner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Douglas J. Turner accept my insurance?
Dr. Douglas J. Turner accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-328-6187 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Thyroid CancerDr. Turner isDistinguished. Learn about Thyroid Cancer.
- Advanced
- Follicular Thyroid CancerDr. Turner isAdvanced. Learn about Follicular Thyroid Cancer.
- Neonatal Severe Hyperparathyroidism
- Papillary Thyroid CancerDr. Turner isAdvanced. Learn about Papillary Thyroid Cancer.
- Parathyroid AdenomaDr. Turner isAdvanced. Learn about Parathyroid Adenoma.
- Parathyroid CancerDr. Turner isAdvanced. Learn about Parathyroid Cancer.
- ThyroidectomyDr. Turner isAdvanced. Learn about Thyroidectomy.
- Experienced
- Esophageal CancerDr. Turner isExperienced. Learn about Esophageal Cancer.
- Hereditary Paraganglioma-Pheochromocytoma Syndrome
- Medullary Thyroid CarcinomaDr. Turner isExperienced. Learn about Medullary Thyroid Carcinoma.
- ParathyroidectomyDr. Turner isExperienced. Learn about Parathyroidectomy.
- PheochromocytomaDr. Turner isExperienced. Learn about Pheochromocytoma.



